Jacob deGrom

Jacob deGrom, Ronald Acuna Jr. Named Comeback Players Of The Year

By Anthony Franco | November 13, 2025 at 11:20pm CDT

The main event of Thursday’s award revelations came with the BBWAA’s announcement that Shohei Ohtani and Aaron Judge repeated as MVP winners. Major League Baseball also conducted its award ceremony tonight, revealing a handful of honors that are not decided by the writers.

Most notably, the league named Jacob deGrom and Ronald Acuña Jr. the respective Comeback Players of the Year. deGrom’s comeback from Tommy John surgery technically occurred at the end of the 2024 season. The two-time Cy Young winner made three late-season appearances last year. He took the ball 30 times this past season and worked to a 2.97 earned run average with 185 strikeouts across 172 2/3 innings. He earned his fifth All-Star nod and finished eighth in AL Cy Young balloting in his age-37 season.

Acuña bounced back from the second ACL tear of his career. The 2023 NL MVP had suffered the season-ending left knee injury on May 26, 2024. He made it back almost one year to the day later. The Braves activated Acuña from the injured list on May 23. He’d return to superstar form, hitting .290/.417/.518 with 21 homers in 95 games. Acuña went back on the injured list around the trade deadline with right Achilles tightness. He only missed a couple weeks and came back to hit .268/.402/.437 down the stretch despite an injury-riddled Atlanta team being well out of contention. It’s the second straight season in which a Brave was named NL Comeback Player of the Year. Chris Sale received that honor last season.

MLB announced a few other honors. Ohtani and Judge repeated as the respective Hank Aaron Award winners as the league’s best hitters. Ohtani yet again won the Edgar Martinez Award as MLB’s best designated hitter. Aroldis Chapman and Edwin Díaz won the respective Reliever of the Year honors. Díaz is free agency’s top reliever coming off a 1.63 ERA across 62 appearances. Chapman turned in a 1.17 ERA over 61 1/3 frames in what is arguably the best season of his fantastic career. He re-signed with the Red Sox on a $13MM deal in August. The BBWAA will reintroduce its own Reliever of the Year Award in 2026.

Brewers president of baseball operations Matt Arnold was named Executive of the Year for the second consecutive season. Milwaukee won an MLB-best 97 games and advanced to the NL Championship Series despite having an Opening Day payroll around $115MM. That was the eighth-lowest mark in the majors.

MLB also announced its 1st and 2nd teams. These are not league specific and are designed to honor the best players at each position. Those are as follows:

1st Team

Catcher: Cal Raleigh, Mariners
First Base: Vladimir Guerrero Jr., Blue Jays
Second Base: Ketel Marte, Diamondbacks
Third Base: José Ramírez, Guardians
Shortstop: Bobby Witt Jr., Royals
Outfield: Aaron Judge, Yankees
Outfield: Julio Rodríguez, Mariners
Outfield: Juan Soto, Mets
Designated hitter: Shohei Ohtani, Dodgers
Starting Pitcher: Tarik Skubal, Tigers
Starting Pitcher: Paul Skenes, Pirates
Starting Pitcher: Yoshinobu Yamamoto, Dodgers
Starting Pitcher: Garrett Crochet, Red Sox
Starting Pitcher: Max Fried, Yankees
Relief Pitcher: Aroldis Chapman, Red Sox
Relief Pitcher: Jhoan Duran, Twins/Phillies

2nd Team

Catcher: Will Smith, Dodgers
First Base: Nick Kurtz, Athletics
Second Base: Brice Turang, Brewers
Third Base: Junior Caminero, Rays
Shortstop: Bo Bichette, Blue Jays
Outfield: Cody Bellinger, Yankees
Outfield: Corbin Carroll, Diamondbacks
Outfield: Pete Crow-Armstrong, Cubs
Designated Hitter: Kyle Schwarber, Phillies
Starting Pitcher: Cristopher Sánchez, Phillies
Starting Pitcher: Hunter Brown, Astros
Starting Pitcher: Zack Wheeler, Phillies
Starting Pitcher: Freddy Peralta, Brewers
Starting Pitcher: Bryan Woo, Mariners
Relief Pitcher: Edwin Díaz, Mets
Relief Pitcher: Andrés Muñoz, Mariners

Tarik Skubal Wins AL Cy Young Award

By Anthony Franco | November 12, 2025 at 6:25pm CDT

For a second straight season, Tarik Skubal is the American League Cy Young award winner. He beat out Garrett Crochet and Hunter Brown, the other two finalists. Skubal received 26 of 30 first-place votes. The other four voters had him second behind Crochet, and those pitchers were 1-2 in some order on every ballot.

Skubal is the first pitcher to win back-to-back Cy Youngs since Jacob deGrom took the NL honors in 2018 and ’19. He’s the 23rd pitcher in MLB history to win the award twice. Skubal cemented himself as one of the two best pitchers on the planet by turning in a 2.21 earned run average across 31 starts. He recorded 241 strikeouts, 13 more than he did during last year’s award-winning season, and won a second straight ERA title.

The Tigers’ star southpaw was fourth in the AL in innings, second in strikeouts behind Crochet, and trailed only Logan Gilbert with a 32.2% strikeout rate (minimum 100 innings). Both FanGraphs and Baseball Reference credited him the most Wins Above Replacement of any AL pitcher. He also had the lowest FIP (2.45) and SIERA (2.71). He tied Brown and Bryan Woo for second in the league with 21 quality starts, one behind Crochet.

Skubal is headed into his final season of arbitration control. With no progress on a long-term extension, there’ll surely be teams trying to pry him out of Detroit. It’s very difficult to imagine the Tigers trading their ace on the heels of two consecutive playoff appearances, though. He’ll likely be back as A.J. Hinch’s Opening Day starter and go for a third consecutive AL Cy Young while trying to get Detroit back to October.

It’s the first top three finish for both Crochet and Brown. The Red Sox could not have asked for more out of Crochet in his first season in Boston. He led the AL in strikeouts and innings pitched (205 1/3) while pitching to a 2.59 ERA over 32 starts. This was only Crochet’s second season as a starting pitcher and his first logging a full starter’s workload. The White Sox had eased him back in the second half of the ’24 campaign to not put too much stress on his arm after years working in relief. He demonstrated he’s capable of maintaining his stuff and ace level over a full season with the Red Sox, who signed him through the 2031 season in April.

Brown’s top three placement earned the Astros an extra pick after the first round of the 2026 draft under the Prospect Promotion Incentive. Houston’s ace turned in a 2.43 ERA across 31 starts. He struck out a career-high 206 batters over 185 1/3 innings. This was Brown’s first time receiving any Cy Young votes. He’s entering arbitration and is under club control for another three seasons.

Voters unanimously had Skubal and Crochet as the AL’s best pitchers in some order. Brown was the consensus choice for third, receiving 24 of 30 third-place votes. The other six third-place nods went to Max Fried. Brown and Fried appeared on all but one ballot apiece. Woo finished comfortably in fifth. Carlos Rodón, Aroldis Chapman, Jacob deGrom, Trevor Rogers and Drew Rasmussen were the other pitchers to receive at least one vote.

Image courtesy of Stephen Brashear, Imagn Images. Full vote tally available via BBWAA.

Rangers Notes: deGrom, Rotation, Jung

By Anthony Franco | August 19, 2025 at 11:30pm CDT

The Rangers will skip Jacob deGrom’s scheduled start Wednesday, president of baseball operations Chris Young told reporters (link via Kennedi Landry of MLB.com). Young framed it as a workload management decision after the star righty experienced minor shoulder fatigue. Manager Bruce Bochy noted that deGrom has already visited team physician Dr. Keith Meister and been cleared of injury.

It doesn’t come as a huge surprise that deGrom is battling fatigue late in the season. He’s up to 24 starts and 140 1/3 innings. It’s a workload that he hadn’t come close to approaching since 2019. The truncated ’20 schedule limited him to 12 starts. deGrom was limited to 15 appearances the following year by elbow inflammation. Shoulder issues kept him to 11 starts in his final season with the Mets. His first two seasons in Texas were largely wiped out by Tommy John surgery.

That makes it all the more remarkable that deGrom has continued to dominate during his age-37 campaign. He owns a 2.76 ERA while striking out 27.3% of batters faced with a huge 14.3% swinging strike rate. His fastball is back into the 98 MPH range on average. deGrom did have his two worst starts in consecutive appearances on July 28 and August 3, but he has rebounded to toss 11 2/3 frames of three-run ball over his past two outings.

Texas has yet to announce a starter for tomorrow’s game. They don’t have a team off day until next Thursday, so even one skipped start won’t be easy to work around. A bullpen game would put a lot of stress on the pitching staff. Kumar Rocker is their only starter who is on optional assignment to Triple-A Round Rock. While there’s no indication that Rocker is dealing with an injury, he hasn’t pitched in the minors since August 7. Jacob Latz has made a few spot starts this season and could be recalled, but he hasn’t gone past two innings in an appearance in a month.

The short-term is less important than taking precautions with deGrom’s health. He’s signed for another two seasons with a club option for 2028. Meanwhile, this season increasingly looks like a lost cause. Texas lost again tonight to drop three games below .500. They’ve lost 10 of 12 and fallen six games back in the Wild Card race.

As their season appears to be slipping away, Opening Day third baseman Josh Jung finds himself on the bench. Bochy has left the former All-Star out of the lineup in each of the past three games. He did make a pinch-hit appearance midway through Tuesday’s contest. Young didn’t sugarcoat things when discussing Jung’s recent lack of playing time.

“There’s been a lot of volatility with Josh,” the front office leader said on Monday (link via Evan Grant of The Dallas Morning News). “There are times when he’s dialed in and the performance is strong, but when it hasn’t been as dialed in, it’s been a little bit more undisciplined. And just inconsistent. Given the kind of team our team is and the way a lot of guys have struggled this year, you can only tolerate so much volatility.”

It’s clear Jung has fallen out of the lineup for performance reasons, not any kind of nagging injury. Rookie Cody Freeman started at the hot corner on Sunday and Monday. Tonight, Josh Smith moved into third base from the right field spot he’d manned of late, drawing Alejandro Osuna into the outfield.

Jung entered play with a .241/.290/.376 batting line over 372 plate appearances. As Young mentioned, he continues to chase would-be balls at a high rate and hasn’t taken many walks. Jung had nevertheless hit fairly well through the end of May, but an atrocious June (.158/.208/.221) led Texas to send him back to Triple-A for a reset. Jung recorded a 10-game hit streak with three home runs immediately after being recalled on July 21. He has dropped back into a slump over the past two weeks, batting .143 with 11 strikeouts in 10 games.

A former eighth overall pick, Jung is on track to surpass the three-year service threshold and will reach arbitration this offseason. The Rangers wouldn’t non-tender him, but it doesn’t seem out of the question that they could consider a change-of-scenery trade. They’ll certainly need to make some changes to a lineup that ranks 24th in MLB in scoring.

Rangers Notes: deGrom, Seager, Carter, Jung

By Nick Deeds | January 19, 2025 at 1:14pm CDT

Rangers right-hander Jacob deGrom is enjoying the first fully healthy offseason he’s had in quite some time after returning from rehab for Tommy John surgery back in September. As noted by Shawn McFarland of the Dallas Morning News, deGrom spoke to reporters about his outlook headed into the 2025 season and revealed that he’s begun throwing off the mound early this winter. The veteran hopes that building up towards pitching in games more slowly over a longer period of time than he has in the past will help him to stay healthy this season.

The 36-year-old is perhaps the very best pitcher in the entire sport when healthy, but maintaining his health has been a struggle over the past half decade. After winning back-to-back NL Cy Young awards with the Mets in 2018 and ’19 and finishing third during the shortened 2020 season, deGrom got off to an unbelievable start in 2021 with a 1.08 ERA and an eye-popping 45.1% strikeout rate. Unfortunately, he was sidelined in early July with forearm and elbow issues that ultimately ended his season. It’s been more of the same ever since, with deGrom making increasingly brief appearances in the majors each year but nonetheless continuing to dominate whenever he’s on the mound.

Since the start of the 2021 season, deGrom has pitched to a 2.01 ERA (200 ERA+) with a 1.63 FIP and 307 strikeouts in 197 1/3 innings. That would be on a shortlist for the greatest pitching seasons of all time if it hadn’t taken deGrom parts of four seasons to accumulate those numbers, and after watching Jordan Montgomery and Max Scherzer depart from their rotation in back-to-back offseasons the Rangers are surely hoping that they’ll get to see what deGrom can do over a full slate of starts this year. That’s something deGrom is fully on board with, as he told reporters (including McFarland) yesterday that his goal is to make 30 starts this year.

While McFarland notes that deGrom has not yet spoken to Rangers brass about his workload for 2025, the idea of a pitcher with deGrom’s injury history making 30 starts can’t be entirely dismissed. After all, southpaw Garrett Crochet made 32 starts with the White Sox last year despite not having pitched more than 65 innings in a season throughout college and his entire professional career due to injuries and time spent in the bullpen. The White Sox made that possible by aggressively managing his innings throughout the second half. He never recorded an out in the fifth inning this year after the calendar flipped to July and his pitch count maxed out at 77 after the All-Star break. Crochet, of course, is more than a decade younger than deGrom, but this sort of aggressive innings management could allow the Rangers to utilize their ace all throughout the regular season and into the playoffs without him needing to throw anything close to 200 innings.

deGrom isn’t the only key player for the Rangers who is hoping for better health in 2024. McFarland relays that third baseman Josh Jung, outfielder Evan Carter, and shortstop Corey Seager are all healthy and ready for Spring Training next month after undergoing surgeries in the fall. Seager underwent sports hernia surgery back in September but resumed baseball activities in November, while Jung and Carter are on a slightly more delayed timeline after undergoing wrist and back surgery respectively in October.

That trio being healthy and effective in 2025 would be a huge boon for the Rangers who failed to defend their 2023 World Series title in the 2024 postseason in large part thanks to a lackluster offense. Rangers hitters produced a collective wRC+ of just 95 last year as Seager was limited to 123 games by injuries while Jung and Carter managed just 46 and 45 games respectively. Seager remained as effective as ever when healthy enough to take the field with a .278/.353/.521 slash line in 533 trips to the plate, but Jung (102 wRC+) and especially Carter (80 wRC+) struggled to keep up with their expected production even when they were on the field due to the nagging nature of their injuries.

While the club has augmented its offense this winter by bringing in Joc Pederson and Jake Burger to replace Nathaniel Lowe in the lineup, better health from Jung and Carter figure to be necessary if the Rangers hope to look more like their 2023 offense, which was third in baseball with a 116 wRC+, than their below-average 2024 club in the upcoming season. Healthy seasons from Jung and Carter would also come with the benefit of pushing outfielder Leody Taveras and infielder Josh Smith into bench roles, giving them one of the deeper positional groups in the sport when fully healthy.

Rangers Activate Jacob deGrom

By Anthony Franco | September 13, 2024 at 5:57pm CDT

Today: The Rangers have officially activated deGrom to make his first start of the 2024 season. In a pair of corresponding moves, the team optioned right-hander Owen White to Triple-A and transferred Corey Seager to the 60-day IL.

Sept. 10: Jacob deGrom makes his season debut on Friday. The Rangers announced that the two-time Cy Young winner will start that evening’s game in Seattle. It will be his first major league appearance since April 2023. deGrom underwent Tommy John surgery last June.

While deGrom’s return comes too late to give Texas any hope of a playoff push, it’s part of what should be a very exciting series. The Rangers will turn to top prospect Kumar Rocker for his MLB debut in Thursday’s opener. deGrom goes the following night. Manager Bruce Bochy told the beat this evening that Max Scherzer will be reinstated from the 15-day injured list to start on Saturday (X link via Shawn McFarland of the Dallas Morning News). Texas will need to create space on the 40-man roster for both Rocker and deGrom.

deGrom has gotten through four rehab starts within the past few weeks. He has mowed down minor league hitters, striking out 15 while allowing only five baserunners over 10 2/3 innings. deGrom tossed four scoreless innings in just 49 pitches with Double-A Frisco on Saturday. Kennedi Landry of MLB.com wrote over the weekend that the Rangers had envisioned deGrom throwing somewhere around 60 pitches in that outing, though they ultimately elected to cap him at four innings when he pitched so efficiently. That could point to a potential 65-75 pitch count during this week’s start.

The Rangers should get three or four starts from deGrom before the end of the season. They’re not going to be of much significance in the standings (beyond the indirect effect of playing the Mariners, a fringe contender, at least once). Getting deGrom back for a few starts should at least give the pitcher and the front office some comfort going into the offseason. deGrom had battled a handful of arm issues late in his Mets tenure. He only managed six starts and 30 1/3 innings with Texas before suffering the significant elbow injury.

Few players are more important to the Rangers’ hope of a return to contention in 2025. deGrom may still be the best pitcher on the planet when healthy. He was utterly dominant for the Mets when he was able to pitch. He’d carried that form over in his first month in a Texas uniform, working to a 2.67 earned run average while striking out almost 40% of batters faced.

deGrom is going into the third season of a five-year, $185MM free agent deal. He’ll make $40MM next season, followed by successive salaries of $38MM and $36MM through 2027. The Tommy John surgery triggered a conditional team option in his deal for 2028. That’s valued at $20MM, though deGrom could push it to $30MM if he finishes in the top five in Cy Young balloting in any of the next three years.

Scherzer, meanwhile, has been out since the start of August because of a shoulder issue. He’d also missed most of the season’s first half rehabbing offseason back surgery and battling a nerve problem in his throwing hand. Scherzer has been limited to eight starts this season, turning in a 3.89 ERA across 39 1/3 innings. The future Hall of Famer will be a free agent next offseason. Scherzer has already declared he intends to continue pitching; he’ll be one of the top risk/reward plays in the starting pitching class.

Rangers Notes: deGrom, Scherzer, Rocker

By Mark Polishuk | September 8, 2024 at 9:45pm CDT

Jacob deGrom’s 2024 debut finally appears imminent, after the two-time Cy Young Award winner completed his fourth and likely final minor league rehab outing on Saturday. DeGrom has seemingly come out of that four-inning, 49-pitch appearance in good health, and is now set to make his return to the majors at some point during the Rangers’ upcoming six-game road trip that begins Tuesday.

“If it all goes well, he’ll be pitching for us next time around,” manager Bruce Bochy told MLB.com’s Kennedi Landry and other reporters. “It’s pretty cool because it’s been a long road as these guys go through the rehab on the Tommy John.”

DeGrom had his Tommy John surgery in June 2023, and last pitched in a big league game on April 28, 2023. After signing a five-year, $185MM free agent contract with Texas during the 2022-23 offseason, deGrom’s only contribution to the Rangers’ World Series season was six starts and 30 1/3 innings, albeit with a very impressive 2.67 ERA and his typically excellent strikeout and walk rates.

Statistics compiled during minor league rehab stints should always be taken with a grain of salt, but deGrom has looked quite sharp in posting an 0.84 ERA over 10 2/3 total innings in the minors. As Landry noted, deGrom has been so dominant that he hasn’t been able to entirely hit his assigned rehab checkpoints. In his start on Saturday, Bochy said deGrom was assigned for four innings or 60 pitches, yet deGrom breezed through Double-A opponents on just 49 pitches — the most he has thrown in any of his four rehab starts.

As the season enters its final three weeks, the Rangers’ title defense has resulted in only a 70-74 record and a longshot bid at a wild card berth. DeGrom won’t be returning to a pennant race, but there’s some obvious benefit in getting back on a big league mound and shaking off some rust in advance of a hopefully normal offseason, and then a standard ramp-up in Spring Training. At age 36 and with just 186 2/3 MLB innings pitched since Opening Day 2021, deGrom’s health history will always make him something of a question mark, yet he has continued to deliver whenever he has been able to pitch.

DeGrom could soon be joined by another veteran ace in Max Scherzer, whose minor league rehab stint got underway Saturday at Triple-A with four hitless innings of work on 53 pitches. Right shoulder fatigue and then triceps discomfort has kept Scherzer on the injured list since the start of August, but a mechanical fix seems to have corrected his triceps issue, and Scherzer looked to be in good form on Saturday.

It seems possible that Scherzer could rejoin the Rangers as early as this week’s road trip, depending on whether or not the team feels he needs any more rehab work to more fully build his pitch count. The Rangers could also activate Scherzer and then allow him to rebuild at the MLB level, either on a limited innings count or with a piggyback pitcher working behind Scherzer.

Heading into the season, Texas planned to have deGrom, Scherzer (who was then recovering from offseason back surgery), and Tyler Mahle (Tommy John surgery) all back around the middle of the year, providing the rotation with some reinforcements down the stretch. While a few setbacks delayed these pitchers on that projected timeline, the bigger problem was other injuries and a lack of hitting that torpedoed the Rangers’ season.

Ironically, this planned surplus of pitching has now come at a time when the Rangers might prefer to look at their future arms. One such hurler is top prospect Kumar Rocker, who has opened some eyes since his own return from a May 2023 Tommy John surgery. The third overall pick of the 2022 draft has an 0.46 ERA over 19 2/3 innings in Double-A ball this season, and an 1.80 ERA in 10 innings since being promoted to Triple-A Round Rock.

These numbers have been impressive enough that Rangers GM Chris Young told reporters (including Evan Grant of the Dallas Morning News) that the team hadn’t closed the door on the possibility of Rocker making his big league debut at some point before the 2024 campaign is over. Grant ran through the various factors involved, including Rocker’s rough 50-inning cap in his first season back from TJ surgery, and the fact that Texas would be putting Rocker on the 40-man roster perhaps earlier than necessary. With three weeks remaining in the season, there’s still time for Rocker to bank a few more Triple-A innings, and if he keeps forcing the issue, the Rangers still have time to perhaps have the right-hander make a cameo after the minor league season is over.

Jacob deGrom To Begin Rehab Assignment

By Darragh McDonald | August 19, 2024 at 6:04pm CDT

Rangers right-hander Jacob deGrom is set to begin a rehab assignment this week. The righty himself tells Jeff Wilson of Rangers Today (X link) that he’ll likely start for Double-A Frisco on Thursday. Manager Bruce Bochy says that it will either be Thursday or Friday, which will be the first of four rehab outings, per Evan Grant of the Dallas Morning News on X. If all goes according to plan, the righty could be back in the majors by September 10.

deGrom underwent Tommy John surgery in June of last year and is now about 14 months removed from that procedure. Once upon a time, it seemed as though deGrom would be part of a trio of heroes riding in to help the Rangers in the second half of 2024. Tyler Mahle also underwent Tommy John surgery last year and was slated for a midseason return, while Max Scherzer opened the season on the IL after undergoing offseason back surgery.

The 2023 World Series champions hoped that they could stay afloat through the first half of 2024 with a strong offense and a rotation mix consisting of Nathan Eovaldi, Jon Gray, Andrew Heaney, Michael Lorenzen, Cody Bradford, Dane Dunning and others. Ideally, they would have gotten stronger throughout the year and made a strong push in defending their title.

It hasn’t exactly played out that way, unfortunately. The team’s hitters have slashed a collective .239/.308/.381 for a 94 wRC+, putting them ahead of just seven teams in the majors. On top of that, the pitching has been a challenging carousel for the club all year. Due to various ailments, no one on the pitching staff has reached 130 innings pitched yet this year, while Eovaldi and Heaney are the only guys currently on the team with more than 100 frames. Lorenzen was traded to the Royals at the deadline and both Gray and Scherzer are currently on the IL.

The combination of injuries and some struggles around the roster have bumped the Rangers towards the back of the American League playoff race. They are 11 games back of the Astros in the West and then 12.5 games out of a Wild Card spot. The Playoff Odds at FanGraphs give them just a 0.2% chance of cracking the postseason while the PECOTA Standings at Baseball Prospectus are slightly more bullish at 0.8%.

At this point, the club is likely viewing deGrom’s return less as a spark plug for a 2024 postseason push and more about getting a few starts under his belt in preparation for the 2025 campaign. He and the Rangers signed a five-year, $185MM deal heading into 2023, though he’s only been able to make six starts on that deal so far, due to his aforementioned surgery.

The club managed to win the World Series last year even without him, but there’s still three years left on that deal, making him a key part of their next chapter. The righty has been one of the better pitchers in the world over the past decade, though the injuries have been an issue in recent years.

From 2014 to the present, he has a 2.53 earned run average in 1,356 1/3 innings pitched, striking out 31% of batters faced while only walking 5.8%. Among pitchers with at least 700 innings in that time, only Clayton Kershaw has a lower ERA while only Scherzer and Chris Sale topped deGrom in terms of strikeout rate.

In recent years, deGrom has provided even higher quality but with less quantity. He topped 200 innings from 2017 to 2019 but hasn’t even hit 100 since. The 2020 season was shortened to just 60 games by the pandemic and then deGrom missed time in the two subsequent seasons due to right side tightness, right forearm tightness and a stress reaction on his right scapula.

From 2020 to the present, he has tossed 254 2/3 innings with a 2.12 ERA and incredible 42% strikeout rate. That punchout rate is tops among all pitchers with at least 250 innings in that stretch, with Spencer Strider a distant second at 36.9%, while only reliever Emmanuel Clase bests deGrom in the ERA department.

At this point, it’s anyone’s guess what kind of form deGrom will be in when he returns. He is now 36 years old and coming off a lengthy injury absence. He also hasn’t been able to make more than 15 starts in a season since 2019.

The Rangers are set to lose both Scherzer and Heaney to free agency in a couple of months. Eovaldi could be joining them, as his deal has a conditional $20MM player option that he unlocks if he totals 300 innings pitched over 2023 and 2024 or finishes in the top five in Cy Young voting this year. Even if he unlocks that option, he might turn it down and head to the open market since he’s having a strong season and could secure a bigger guarantee over a longer deal in free agency.

If Eovaldi does depart, then the 2025 Ranger rotation on paper is deGrom, Gray, Mahle, Dunning and Bradford, with both Gray and Mahle slated for free agency after next year. Jack Leiter and Owen White are each on the 40-man roster but both have dealt with control problems.

Taken all together, deGrom’s form in the coming years figures to be a significant factor for the Rangers, considering how much they have invested in him and that there’s not a lot of long-term certainty in the rotation picture.

AL Notes: Verlander, Garcia, Buxton, Paddack, Rangers, Skubal

By Mark Polishuk | August 18, 2024 at 10:34pm CDT

Justin Verlander “felt strong” during a bullpen session today in Houston, Astros manager Joe Espada told reporters (including Matt Kawahara of the Houston Chronicle), which should line Verlander up to return to the rotation on Wednesday when the Astros face the Red Sox. A neck strain has kept Verlander from pitching in the majors since June 9, and he has amassed only 57 innings this season due both this current ailment and a bout of shoulder inflammation coming out of Spring Training. However, Verlander has completed two minor league rehab outings and today’s bullpen session looks like the final checkpoint on his path to recovery.

While things are looking promising for Verlander, Luis Garcia is more of a question mark. The Athletic’s Chandler Rome wrote (via X) that as of Friday, Garcia hadn’t yet resumed throwing since he was shut down due to soreness over two weeks ago. This is the second time Garcia has hit a setback in his recovery from Tommy John surgery, and since Garcia went under the knife in May 2023, a normal rehab timeline would’ve had him ready to return to the majors by this point over 15 months past his procedure date. Though the Astros have said Garcia might return as a reliever rather than as a starter, he is running short on time to fully ramp up his readiness to rejoin Houston’s pitching staff in any capacity.

AL West Notes: Verlander, Rodriguez, deGrom

By Mark Polishuk | August 10, 2024 at 2:06pm CDT

Justin Verlander is slated to make a rehab start for Triple-A Sugar Land today, marking his first game action since June 9. Astros manager Joe Espada told reporters (including Matt Kawahara and Matt Young of the Houston Chronicle) that the loose plan is for Verlander to throw three innings or 50 pitches in the first of what is expected to be a two-outing rehab stint, though there’s plenty of fluidity built in as the 41-year-old ace works his way back from a neck strain.

If all goes well, Verlander would likely be activated for the start of the Astros’ series with the Orioles that begins on August 22. Verlander would become the sixth member of a six-man rotation Houston is planning to deploy during a busy stretch of the schedule, as after receiving three off-days within the first 15 days of August, the Astros then play every day from August 16 through September 2. Assuming Verlander returns in his usual top-of-the-rotation form, he’ll be a giant boost to a Houston team that is battling the Mariners for the AL West title, and will again be looking to make another deep playoff run. Between this neck problem and a season-opening bout of shoulder inflammation, Verlander has been limited to 57 innings in his 19th Major League season, but he has a solid 3.95 ERA when available to pitch.

Latest On Rangers’ Rotation, Trade Possibilities

By Steve Adams | July 25, 2024 at 1:36pm CDT

The Rangers have patched together their rotation for much of the season as they anticipate the returns of veterans Max Scherzer, Tyler Mahle and Jacob deGrom. Scherzer has already returned. Mahle is set to make his fifth minor league rehab start today and should make his Rangers debut before long. It’ll be a bit longer before deGrom makes it back, but he tossed a 40-pitch bullpen just yesterday, per Jeff Wilson of RangersToday.com. Left-hander Cody Bradford is on a minor league rehab assignment and expected to return soon, though Evan Grant of the Dallas Morning News writes that he’ll work out of the bullpen upon his return. Texas reinstated righty Dane Dunning from the injured list earlier today, too. He’s in the ’pen for now but could move back to a starting role depending on how the next week goes.

What once was a starting pitching hodgepodge looks increasingly enviable. If Mahle is cleared to return after today’s start, he’ll join Scherzer, Nathan Eovaldi, Jon Gray, Michael Lorenzen, Andrew Heaney and Dunning as viable rotation options, with Bradford in the bullpen and deGrom looming on the horizon. That’s nine MLB-caliber starters, to say nothing of veteran starter Jose Ureña (who started six games but is in the bullpen presently).

With so many options suddenly at their fingertips, there’s been plenty of speculation about the Rangers trading from that stockpile of arms — even as they narrow the deficit in the postseason hunt. Texas has won four straight games. The Mariners have lost three straight. The Rangers now sit only three games back of the first-place Astros in the West and are just 5.5 games out in the Wild Card hunt. They’re not going to operate as a pure seller, but Ken Rosenthal of The Athletic suggests that Lorenzen or perhaps even Gray could be moved before Tuesday’s trade deadline.

Lorenzen, 32, signed with the Rangers on a one-year, $4.5MM deal in spring training. It was a bargain price for a veteran righty coming off a solid season, and he’s proven to be well worth the investment. He’s pitched 97 innings over the course of 17 starts and turned in a 3.53 ERA. Lorenzen’s 18.5% strikeout rate and 11.6% walk rate both leave plenty to be desired and point to some likely ERA regression, but he’s been precisely the type of veteran rotation stabilizer the Rangers hoped to be acquiring when signing him.

As of deadline day, Lorenzen will have just $1.5MM of that base salary yet to be paid out. He’s already picked up $800K of innings-based incentives and will get another $200K when he reaches 100 innings, likely in his next start. Assuming that comes with the Rangers — he’s their probable starter Saturday — a new team would be on the hook for the remaining portion of his base and additional incentives he’d unlock by reaching 120 innings ($300K), 140 innings ($350K), 160 innings ($400K) and 180 innings ($450K). He’s on pace to barely reach that final milestone.

At most, a team adding Lorenzen would pay around $1.5MM in base salary and an additional $1.5MM worth of incentives. If Lorenzen is pitching well enough to reach that 180-inning mark, it’d be considered money well spent. If nothing else, a budget-conscious team looking to add a stable starter (e.g. Twins, Guardians) could view Lorenzen as an affordable option.

Gray would be a more surprising trade candidate. He’s in the third season of a four-year, $56MM contract that’s paying $13MM both this year and next. Thus far, he’s posted 94 innings of 3.73 ERA ball on the season. While Gray’s 19.7% strikeout rate is the lowest of his career (aside from the shortened 2020 season), his 5.8% walk rate is a career-best mark. He’s still averaging 95 mph with his heater, while his opponents’ chase rate and swinging-strike rate are roughly in line with his 2022-23 marks.

Rosenthal also cites a pair of names the Rangers would prefer to hang onto even as they ponder trading from their rotation depth: Eovaldi and Heaney. The former is well on his way to vesting a $20MM player option for the 2025 season. That option would decrease his trade value — a new team would be stuck with the $20MM in the event of a major, post-trade injury. Beyond that, Eovaldi has been one of the team’s best arms this season, notching a 3.31 ERA, 24.6% strikeout rate and 6.1% walk rate in 106 innings. He’d likely be ticketed for their playoff rotation, should they get there. And, even if they don’t, the Rangers might simply hope Eovaldi stays healthy and enjoys pitching in his home state enough that he’d pick up that player option for the 2025 season.

As for Heaney, he’s turned things around after a shaky first season in Texas. The veteran southpaw boasts a 3.60 ERA, 23.5% strikeout rate and 6.8% walk rate in exactly 100 innings. He’s a free agent at season’s end, so one would imagine he’s an on-paper trade candidate in this scenario where Texas deals from its excess. However, the Rangers don’t have an established left-hander in their bullpen. Brock Burke was excellent in 2022 but took a step back in ’23 and was optioned earlier this season after being shelled through 9 2/3 innings. Rookie Jacob Latz has a solid 3.68 ERA in 36 2/3 innings, but he’s walked 13.5% of his opponents. Bradford could possibly fill that role, but he’s yet to return from a stress reaction in his ribcage.

Heaney has experience pitching both as a starter and reliever, including during his time with Texas. He’s throwing well right now but would likely be pushed out of a theoretical postseason rotation. In that setting, he could slide into the bullpen and match up against tough lefties and/or provide multiple innings in long relief.

Load More Posts

Show all

Headlines

Jacob deGrom

Navigation

MLBTR INFO

Connect